| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.28▼ | 2.28▼ | 2.29▼ | 2.44▼ | 2.52▼ |
| MA10 | 2.28▼ | 2.29▼ | 2.33▼ | 2.48▼ | 2.60▼ |
| MA20 | 2.28▼ | 2.35▼ | 2.41▼ | 2.53▼ | 2.51▼ |
| MA50 | 2.29▼ | 2.43▼ | 2.48▼ | 2.68▼ | 1.97▲ |
| MA100 | 2.35▼ | 2.49▼ | 2.47▼ | 2.53▼ | 1.98▲ |
| MA200 | 2.42▼ | 2.48▼ | 2.58▼ | 2.12▲ | 3.41▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.003▼ | -0.014▼ | -0.012▼ | -0.072▼ |
| RSI | 40.691▼ | 29.964▼ | 25.877▼ | 37.338▼ | 48.576▼ |
| STOCH | 6.667▼ | 15.502▼ | 7.335▼ | 37.862 | 24.009 |
| WILL %R | -100.000▼ | -93.548▼ | -95.833▼ | -95.789▼ | -92.308▼ |
| CCI | -87.263 | -82.037 | -94.911 | -156.366▼ | -79.272 |
|
Tuesday, May 12, 2026 01:27 PM
Acumen Pharmaceuticals Inc (ABOS) showcases promising developments in Alzheimer's treatment and cost management, despite reporting a net loss for the quarter.
|
|
Tuesday, May 12, 2026 06:27 AM
Acumen Pharmaceuticals (NASDAQ:ABOS) said its Phase 2 ALTITUDE-AD trial of sabirnetug remains on track, with top-line results expected late in 2026, as the company continues to advance its broader ...
|
|
Tuesday, May 12, 2026 04:17 AM
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/05/26 | 2.35 | 2.40 | 2.26 | 2.28 | 387,723 |
| 14/05/26 | 2.51 | 2.52 | 2.375 | 2.39 | 258,144 |
| 13/05/26 | 2.48 | 2.535 | 2.465 | 2.49 | 176,185 |
| 12/05/26 | 2.58 | 2.615 | 2.44 | 2.48 | 247,013 |
| 11/05/26 | 2.54 | 2.735 | 2.54 | 2.57 | 428,263 |
| 08/05/26 | 2.50 | 2.57 | 2.41 | 2.56 | 161,541 |
| 07/05/26 | 2.54 | 2.59 | 2.40 | 2.47 | 327,847 |
| 06/05/26 | 2.55 | 2.615 | 2.515 | 2.57 | 263,771 |
| 05/05/26 | 2.50 | 2.55 | 2.47 | 2.52 | 255,093 |
| 04/05/26 | 2.39 | 2.525 | 2.35 | 2.48 | 310,828 |
|
|
||||
|
|
||||
|
|